Nestor, C.E.* ; Lentini, A.* ; Hägg Nilsson, C.* ; Gawel, D.R.* ; Gustafsson, M.* ; Mattson, L.* ; Wang, H.* ; Rundquist, O.* ; Meehan, R.R.* ; Klocke, B.* ; Seifert, M.* ; Hauck, S.M. ; Laumen, H. ; Zhang, H.* ; Benson, M.*
5-hydroxymethylcytosine remodeling precedes lineage specification during differentiation of human CD4+ T cells.
Cell Rep. 16, 559-570 (2016)
5-methylcytosine (5mC) is converted to 5-hydroxymethylcytosine (5hmC) by the TET family of enzymes as part of a recently discovered active DNA de-methylation pathway. 5hmC plays important roles in regulation of gene expression and differentiation and has been implicated in T cell malignancies and autoimmunity. Here, we report early and widespread 5mC/5hmC remodeling during human CD4(+) T cell differentiation ex vivo at genes and cell-specific enhancers with known T cell function. We observe similar DNA de-methylation in CD4(+) memory T cells in vivo, indicating that early remodeling events persist long term in differentiated cells. Underscoring their important function, 5hmC loci were highly enriched for genetic variants associated with T cell diseases and T-cell-specific chromosomal interactions. Extensive functional validation of 22 risk variants revealed potentially pathogenic mechanisms in diabetes and multiple sclerosis. Our results support 5hmC-mediated DNA de-methylation as a key component of CD4(+) T cell biology in humans, with important implications for gene regulation and lineage commitment.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Hematopoietic Stem-cells; Dna Methylation; Autoimmune-disease; Enhancer Activity; Wide Association; Gene-expression; Risk Loci; Tet2; State; 5-methylcytosine
Keywords plus
Language
Publication Year
2016
Prepublished in Year
HGF-reported in Year
2016
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 16,
Issue: 2,
Pages: 559-570
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30502 - Diabetes: Pathophysiology, Prevention and Therapy
Research field(s)
Enabling and Novel Technologies
Genetics and Epidemiology
PSP Element(s)
G-505700-001
G-521600-002
Grants
Copyright
Erfassungsdatum
2016-06-29